Clarion Raises $10.0M Seed Round

Nutriband Inc.

At Nutriband and our subsidiaries, our core focus is to use innovative drug delivery systems and devices to improve patient outcomes, specifically targeting the Global Opioid epidemic. Fentanyl and other opioid based transdermal medications unfortunately play a role in a significant number of opioid deaths each year with no solution currently available. Working with our Clinical subsidiary 4P Therapeutics we have developed a technology called AVERSA which we believe with FDA approval will revolutionize the safety standard for these medications and save countless lives per year.

Pathways

Pathways works directly with concrete producers, combining hands-on support with purpose-built software to manage the data collection, analysis, and verification behind Environmental Product Declarations. Instead of a months-long process that pulls teams away from day-to-day operations, producers receive EPDs in weeks and stay focused on delivering and winning work. We keep business moving today, and help build a future where sustainability doesn’t stand in the way of progress, but moves alongside it. Pathways is designed to keep producers moving.